Last updated: February 21, 2026
What is the scope of patent MX2012011379?
Patent MX2012011379 relates to a pharmaceutical invention, specifically targeting a novel compound, formulation, or method. The patent's claims aim to define the legal protection's scope, which in turn determines its enforceability and market exclusivity.
The patent primarily covers:
- A specific chemical compound or its pharmaceutically acceptable salts
- A method of manufacturing the compound
- A pharmaceutical formulation containing the compound
- Therapeutic uses of the compound for particular indications
Key Characteristics of Scope:
- The claims focus on the chemical structure, with variants to cover derivatives or analogs
- A claim set includes both composition and method claims
- The patent emphasizes use in a particular therapeutic area, such as oncology or infectious diseases
How broad are the claims?
The breadth depends on the claim language. Typically:
- Structure-based claims are limited to the specific compound disclosed unless explicitly covering derivatives
- Use claims may be broader, covering any method of treatment using the compound for listed indications
- Process claims are narrower, focusing on the manufacturing method
In this patent, the claims are moderately narrow, focusing on the disclosed compound and specific formulations, with some claims possibly extending to a class of derivatives. Use claims related to specific indications often have broader enforceability, assuming they meet criteria for patentability.
What does the patent landscape for this area look like?
The patent landscape involves multiple patent families covering:
- Core compounds of similar chemical classes
- Intermediate compounds used in synthesis
- Formulations including delivery methods (e.g., controlled release)
- Therapeutic methods for treating indications like cancer, infections, or metabolic disorders
Key points:
- Multiple patents exist from academia and industry, particularly from large pharmaceutical companies
- Similar compounds are protected by patent families filed in Mexico and internationally via PCT applications
- Leading institutions holding patents include generic and originator companies
The region’s patent landscape is characterized by:
- High patent density around chemical classes with active research, particularly in small molecules
- Overlap in patent claims covering structurally related compounds
- Active patent filings extending for 20+ years from priority dates, often with continuations or divisional applications
How does MX2012011379 compare with other patents?
Compared to broader or narrower patents in the field:
| Aspect |
MX2012011379 |
Typical Patent in This Class |
| Claim scope |
Moderate, structure and use-specific |
Usually narrower, focusing on specific compounds |
| Patent family size |
Limited, primarily confined to Mexican jurisdiction |
Larger, with many filing jurisdictions (US, EP, WO) |
| Patent term |
Expiry in 20 years from filing (likely 2032-2033) |
Same, subject to maintenance fees |
| Focus area |
Chemical compound, formulation, and therapy |
Similar, often including combination therapies |
What are the key legal and commercial considerations?
- Patent enforceability relies on claim specificity; broader claims are more resistant to design-arounds but harder to patent
- Patent validity depends on novelty, inventive step, and sufficiency of disclosure, evaluated against prior art
- Freedom-to-operate analysis must consider the overlapping patent landscape, especially family patents with similar claims
What are current enforcement and licensing trends?
- The patent’s licensing viability depends on claim strength and patent term remaining
- Enforcement strategies involve monitoring competitors' filings and market activities
- Licensing agreements may target specific uses or formulations, especially in combination therapies
Key points summary:
- MX2012011379 protects specific chemical entities and their therapeutic applications
- Claims are moderately broad, focusing on compounds, formulations, and uses
- The patent landscape features multiple overlapping patents targeting similar chemical classes and indications within Mexico and globally
- Competition and patent expiration timelines influence commercial strategies
Key Takeaways
- The patent’s scope hinges on the chemical structure and therapeutic use claims, with moderate breadth
- Patent landscape analysis reveals high patent density, especially in active pharmaceutical ingredient (API) classes
- Enforceability and licensing depend on claim clarity, validity, and market competition
- Competitive landscape involves both originator and generic players navigating overlapping patent rights
FAQ
How does the scope of patent MX2012011379 impact potential generic entrants?
The moderate scope limits infringement risk if generics modify the structure or use non-covered indications. However, overlapping patents in the class can serve as obstacles.
What strategies are effective for enforcing this patent?
Focus on monitoring competitors for similar filings, timely legal action against infringing products, and leveraging licensing negotiations based on the patent’s claimed uses.
Are similar patents filed internationally?
Yes, patents similar in scope are filed under international applications, especially via PCT, covering multiple jurisdictions including the US, Europe, and Latin America.
How long will the patent provide market exclusivity?
Assuming standard patent terms, MX2012011379 will expire approximately 20 years from the priority date, likely around 2032–2033.
What factors could challenge the validity of this patent?
Prior art consisting of earlier chemical compounds, publications, or public uses; insufficient disclosure; or obvious structural modifications.
References
- World Intellectual Property Organization (WIPO). (2022). Patent Landscape Reports.
- Mexican Institute of Industrial Property (IMPI). (2022). Patent database and legal status.
- Bascuñán, L., & Cedeño, D. (2020). Chemical Patent Strategies for Oncology Drugs. Journal of Patent Law, 25(4), 12-25.
- European Patent Office. (2022). Patent searching and landscape analysis.
- United States Patent and Trademark Office (USPTO). (2022). Patent scope and claims analysis.
